Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Ertugliflozin and Incident Obstructive Sleep Apnea: An Analysis from the VERTIS CV Trial
Sleep medicine, 2022-12, Vol.100, p.S249-S250
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
IDF2022-0796 Sustained weight loss with ertugliflozin in patients with T2D and atherosclerotic cardiovascular disease in VERTIS CV
Diabetes research and clinical practice, 2023-03, Vol.197, p.110329, Article 110329
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
Annals of medicine (Helsinki), 2008, Vol.40 (6), p.456-464
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged less than65 Versus =65 Years With Coronary Heart Disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] Study)
The American journal of cardiology, 2009, Vol.103 (5), p.577
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
2.P.91 Effect of Lifibrol on the metabolism of LDL-apo B and apo A-I in moderate hypercholesterolemia
Atherosclerosis, 1997-10, Vol.134 (1-2), p.135-135
1997
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PO23-736 EFFECT OF ADHERENCE DIFFERENCES TO ATORVASTATIN 80 MG (A80) VERSUS SIMVASTATIN 20-40 MG (S20-40) IN CORONARY HEART DISEASE (CHD) PATIENTS
Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.196-196
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PO23-743 EFFECT OF INTENSIVE VERSUS STANDARD STATIN THERAPY IN YOUNGER AND OLDER CORONARY HEART DISEASE (CHD) PATIENTS IN THE IDEAL TRIAL
Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.198-198
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PO23-741 ON-TREATMENT HDL-C LEVELS AND RISK OF MAJOR CARDIOVASCULAR EVENTS IN THE IDEAL TRIAL
Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.197-197
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
INTENSIVE ATORVASTATIN THERAPY REDUCES RISK OF CARDIOVASCULAR EVENTS BEYOND THE FIRST EVENT IN PATIENTS WITH MULTIPLE EVENTS
Atherosclerosis. Supplements, 2008-05, Vol.9 (1), p.8-8
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
LDL CHOLESTEROL GOAL ATTAINMENTS IN THE IDEAL STUDY
Atherosclerosis. Supplements, 2008-05, Vol.9 (1), p.205-206
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PO23-735 RISK REDUCTION WITH INTENSIVE VERSUS STANDARD STATIN THERAPY IN ACUTE CORONARY SYNDROME: IDEAL TRIAL
Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.196-196
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
LB-OR-2 HIGH HDL-C AND CHD RISK IN STATIN-TREATED CHD PATIENTS: ANALYSIS OF INCREMENTAL DECREASE IN ENDPOINTS THROUGH AGGRESSIVE LIPID-LOWERING (IDEAL) TRIAL
Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.227-227
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PO23-737 A COMPARISON OF THE ASSOCIATION OF ON-TREATMENT LIPID AND APOLIPOPROTEIN PARAMETERS TO CARDIOVASCULAR EVENTS IN IDEAL AND TNT
Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.196-196
2007
Volltextzugriff (PDF)
1 – 13 von 13
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen